The management of metastatic clear-cell renal-cell carcinoma has been revolutionized by the approval of targeted therapies. These targeted therapies have, however, been unable to provide robust complete responses in metastatic clear-cell renal-cell carcinoma. The authors of this Review discuss the role of immunotherapeutic approaches in the management of this disease.
- Swethajit Biswas
- Tim Eisen